Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

189.08
+4.072.20%
Post-market: 190.000.9200+0.49%19:58 EDT
Volume:833.40K
Turnover:156.91M
Market Cap:11.64B
PE:-32.37
High:189.40
Open:186.71
Low:186.00
Close:185.01
52wk High:198.00
52wk Low:95.49
Shares:61.56M
Float Shares:58.65M
Volume Ratio:0.92
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8403
EPS(LYR):-5.8403
ROE:-8.47%
ROA:5.22%
PB:2.70
PE(LYR):-32.37

Loading ...

May 04, 2021

Major Issues Report

8-K - Current report
Apr 29, 2021

Major Issues Report

8-K - Current report
Apr 23, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 23, 2021

Major Issues Report

8-K - Current report
Apr 22, 2021

Major Issues Report

8-K - Current report
Apr 20, 2021

Major Issues Report

8-K - Current report
Mar 23, 2021

Major Issues Report

8-K - Current report
Mar 22, 2021

Major Issues Report

8-K - Current report
Feb 23, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 23, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2021

Major Issues Report

8-K - Current report
Feb 03, 2021

Major Issues Report

8-K - Current report
Jan 12, 2021

Major Issues Report

8-K - Current report
Nov 17, 2020

Major Issues Report

8-K - Current report
Nov 03, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments